 | • レポートコード：QYR2104Z4171 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、非侵襲的癌診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（臨床化学、免疫化学/イムノアッセイ、分子診断、その他）、用途別市場規模（固形がん、血液がん、肺がん、乳がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・非侵襲的癌診断の市場動向 ・企業の競争状況、市場シェア ・非侵襲的癌診断の種類別市場規模（臨床化学、免疫化学/イムノアッセイ、分子診断、その他） ・非侵襲的癌診断の用途別市場規模（固形がん、血液がん、肺がん、乳がん、その他） ・非侵襲的癌診断の北米市場規模2016-2027（アメリカ、カナダ） ・非侵襲的癌診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・非侵襲的癌診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・非侵襲的癌診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・非侵襲的癌診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Precision Therapeutics, Inc. (U.S.)、A&G Pharmaceutical, Inc. (U.S.)、Affymetrix Inc. (U.S.)、AVIVA Biosciences Corporation (U.S.)、BIOVIEW Inc. (U.S.)、Laboratory Corporation of America Holdings (LabCorp) (U.S.)、Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)、Digene Corporation (U.S.)、Gen-Probe Incorporated (U.S.)、IVDiagnostics, Inc. (U.S.)） ・結論 |
Non-invasive diagnosis is a procedure of identifying a disease without or with minimal incision of the body. These methods involve different techniques such as identifying genetic structure, biomarkers, changes in molecular biology, along with imaging technologies. Cancer is a disease related to genetic alteration of the cells and therefore causing uncontrolled growth and forming tumor like structure. Imaging is the preferred method of cancer detection but cannot have genetic access; on the other hand biopsies which have genetic access are complicated and difficult to perform repetitively during the course of cancer diagnosis and therapy. Therefore newer techniques developed in lines with non invasive diagnosis such as molecular diagnosis, serum based immunoassays and chemical tests to identify chemical components in the body especially from blood and urine. All these procedures are performed either with non-surgical or minimal surgical procedures; therefore these non-invasive cancer diagnostic techniques are becoming more and more popular among healthcare practitioners.
Market Analysis and Insights: Global Noninvasive Cancer Diagnostics Market
The global Noninvasive Cancer Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Noninvasive Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Noninvasive Cancer Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Noninvasive Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Noninvasive Cancer Diagnostics market.
Global Noninvasive Cancer Diagnostics Scope and Market Size
Noninvasive Cancer Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Noninvasive Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Others
Segment by Application
Solid Tumors
Blood Cancer
Lung Cancer
Breast Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Precision Therapeutics, Inc. (U.S.)
A&G Pharmaceutical, Inc. (U.S.)
Affymetrix Inc. (U.S.)
AVIVA Biosciences Corporation (U.S.)
BIOVIEW Inc. (U.S.)
Laboratory Corporation of America Holdings (LabCorp) (U.S.)
Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
Digene Corporation (U.S.)
Gen-Probe Incorporated (U.S.)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Noninvasive Cancer Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Clinical Chemistry
1.2.3 Immunochemistry/Immunoassay
1.2.4 Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Noninvasive Cancer Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Solid Tumors
1.3.3 Blood Cancer
1.3.4 Lung Cancer
1.3.5 Breast Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Noninvasive Cancer Diagnostics Market Perspective (2016-2027)
2.2 Noninvasive Cancer Diagnostics Growth Trends by Regions
2.2.1 Noninvasive Cancer Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Noninvasive Cancer Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Noninvasive Cancer Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Noninvasive Cancer Diagnostics Industry Dynamic
2.3.1 Noninvasive Cancer Diagnostics Market Trends
2.3.2 Noninvasive Cancer Diagnostics Market Drivers
2.3.3 Noninvasive Cancer Diagnostics Market Challenges
2.3.4 Noninvasive Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Noninvasive Cancer Diagnostics Players by Revenue
3.1.1 Global Top Noninvasive Cancer Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Noninvasive Cancer Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Noninvasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Noninvasive Cancer Diagnostics Revenue
3.4 Global Noninvasive Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Noninvasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Noninvasive Cancer Diagnostics Revenue in 2020
3.5 Noninvasive Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Noninvasive Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Noninvasive Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Noninvasive Cancer Diagnostics Breakdown Data by Type
4.1 Global Noninvasive Cancer Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Noninvasive Cancer Diagnostics Forecasted Market Size by Type (2022-2027)
5 Noninvasive Cancer Diagnostics Breakdown Data by Application
5.1 Global Noninvasive Cancer Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Noninvasive Cancer Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Noninvasive Cancer Diagnostics Market Size (2016-2027)
6.2 North America Noninvasive Cancer Diagnostics Market Size by Type
6.2.1 North America Noninvasive Cancer Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Noninvasive Cancer Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Noninvasive Cancer Diagnostics Market Size by Type (2016-2027)
6.3 North America Noninvasive Cancer Diagnostics Market Size by Application
6.3.1 North America Noninvasive Cancer Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Noninvasive Cancer Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Noninvasive Cancer Diagnostics Market Size by Application (2016-2027)
6.4 North America Noninvasive Cancer Diagnostics Market Size by Country
6.4.1 North America Noninvasive Cancer Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Noninvasive Cancer Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Noninvasive Cancer Diagnostics Market Size (2016-2027)
7.2 Europe Noninvasive Cancer Diagnostics Market Size by Type
7.2.1 Europe Noninvasive Cancer Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Noninvasive Cancer Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Noninvasive Cancer Diagnostics Market Size by Type (2016-2027)
7.3 Europe Noninvasive Cancer Diagnostics Market Size by Application
7.3.1 Europe Noninvasive Cancer Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Noninvasive Cancer Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Noninvasive Cancer Diagnostics Market Size by Application (2016-2027)
7.4 Europe Noninvasive Cancer Diagnostics Market Size by Country
7.4.1 Europe Noninvasive Cancer Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Noninvasive Cancer Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Noninvasive Cancer Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Noninvasive Cancer Diagnostics Market Size (2016-2027)
9.2 Latin America Noninvasive Cancer Diagnostics Market Size by Type
9.2.1 Latin America Noninvasive Cancer Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Noninvasive Cancer Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Noninvasive Cancer Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Noninvasive Cancer Diagnostics Market Size by Application
9.3.1 Latin America Noninvasive Cancer Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Noninvasive Cancer Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Noninvasive Cancer Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Noninvasive Cancer Diagnostics Market Size by Country
9.4.1 Latin America Noninvasive Cancer Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Noninvasive Cancer Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Noninvasive Cancer Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Precision Therapeutics, Inc. (U.S.)
11.1.1 Precision Therapeutics, Inc. (U.S.) Company Details
11.1.2 Precision Therapeutics, Inc. (U.S.) Business Overview
11.1.3 Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
11.1.4 Precision Therapeutics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.1.5 Precision Therapeutics, Inc. (U.S.) Recent Development
11.2 A&G Pharmaceutical, Inc. (U.S.)
11.2.1 A&G Pharmaceutical, Inc. (U.S.) Company Details
11.2.2 A&G Pharmaceutical, Inc. (U.S.) Business Overview
11.2.3 A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
11.2.4 A&G Pharmaceutical, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.2.5 A&G Pharmaceutical, Inc. (U.S.) Recent Development
11.3 Affymetrix Inc. (U.S.)
11.3.1 Affymetrix Inc. (U.S.) Company Details
11.3.2 Affymetrix Inc. (U.S.) Business Overview
11.3.3 Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
11.3.4 Affymetrix Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.3.5 Affymetrix Inc. (U.S.) Recent Development
11.4 AVIVA Biosciences Corporation (U.S.)
11.4.1 AVIVA Biosciences Corporation (U.S.) Company Details
11.4.2 AVIVA Biosciences Corporation (U.S.) Business Overview
11.4.3 AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Introduction
11.4.4 AVIVA Biosciences Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.4.5 AVIVA Biosciences Corporation (U.S.) Recent Development
11.5 BIOVIEW Inc. (U.S.)
11.5.1 BIOVIEW Inc. (U.S.) Company Details
11.5.2 BIOVIEW Inc. (U.S.) Business Overview
11.5.3 BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
11.5.4 BIOVIEW Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.5.5 BIOVIEW Inc. (U.S.) Recent Development
11.6 Laboratory Corporation of America Holdings (LabCorp) (U.S.)
11.6.1 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Company Details
11.6.2 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Business Overview
11.6.3 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Introduction
11.6.4 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.6.5 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Recent Development
11.7 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
11.7.1 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Company Details
11.7.2 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Business Overview
11.7.3 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
11.7.4 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.7.5 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Recent Development
11.8 Digene Corporation (U.S.)
11.8.1 Digene Corporation (U.S.) Company Details
11.8.2 Digene Corporation (U.S.) Business Overview
11.8.3 Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Introduction
11.8.4 Digene Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.8.5 Digene Corporation (U.S.) Recent Development
11.9 Gen-Probe Incorporated (U.S.)
11.9.1 Gen-Probe Incorporated (U.S.) Company Details
11.9.2 Gen-Probe Incorporated (U.S.) Business Overview
11.9.3 Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Introduction
11.9.4 Gen-Probe Incorporated (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.9.5 Gen-Probe Incorporated (U.S.) Recent Development
11.10 IVDiagnostics, Inc. (U.S.)
11.10.1 IVDiagnostics, Inc. (U.S.) Company Details
11.10.2 IVDiagnostics, Inc. (U.S.) Business Overview
11.10.3 IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
11.10.4 IVDiagnostics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021)
11.10.5 IVDiagnostics, Inc. (U.S.) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Noninvasive Cancer Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Clinical Chemistry
Table 3. Key Players of Immunochemistry/Immunoassay
Table 4. Key Players of Molecular Diagnostics
Table 5. Key Players of Others
Table 6. Global Noninvasive Cancer Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Noninvasive Cancer Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Noninvasive Cancer Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Noninvasive Cancer Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Noninvasive Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Noninvasive Cancer Diagnostics Market Share by Regions (2022-2027)
Table 12. Noninvasive Cancer Diagnostics Market Trends
Table 13. Noninvasive Cancer Diagnostics Market Drivers
Table 14. Noninvasive Cancer Diagnostics Market Challenges
Table 15. Noninvasive Cancer Diagnostics Market Restraints
Table 16. Global Noninvasive Cancer Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Noninvasive Cancer Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Noninvasive Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Noninvasive Cancer Diagnostics as of 2020)
Table 19. Ranking of Global Top Noninvasive Cancer Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Noninvasive Cancer Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Noninvasive Cancer Diagnostics Product Solution and Service
Table 23. Date of Enter into Noninvasive Cancer Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Noninvasive Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Noninvasive Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Noninvasive Cancer Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Noninvasive Cancer Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Noninvasive Cancer Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Noninvasive Cancer Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Noninvasive Cancer Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Noninvasive Cancer Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Noninvasive Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Noninvasive Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Noninvasive Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Noninvasive Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Noninvasive Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Noninvasive Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Noninvasive Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Noninvasive Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Noninvasive Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Noninvasive Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Noninvasive Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Noninvasive Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Noninvasive Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Noninvasive Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Noninvasive Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Noninvasive Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Noninvasive Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Noninvasive Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Precision Therapeutics, Inc. (U.S.) Company Details
Table 64. Precision Therapeutics, Inc. (U.S.) Business Overview
Table 65. Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 66. Precision Therapeutics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Precision Therapeutics, Inc. (U.S.) Recent Development
Table 68. A&G Pharmaceutical, Inc. (U.S.) Company Details
Table 69. A&G Pharmaceutical, Inc. (U.S.) Business Overview
Table 70. A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 71. A&G Pharmaceutical, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 72. A&G Pharmaceutical, Inc. (U.S.) Recent Development
Table 73. Affymetrix Inc. (U.S.) Company Details
Table 74. Affymetrix Inc. (U.S.) Business Overview
Table 75. Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 76. Affymetrix Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Affymetrix Inc. (U.S.) Recent Development
Table 78. AVIVA Biosciences Corporation (U.S.) Company Details
Table 79. AVIVA Biosciences Corporation (U.S.) Business Overview
Table 80. AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Product
Table 81. AVIVA Biosciences Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 82. AVIVA Biosciences Corporation (U.S.) Recent Development
Table 83. BIOVIEW Inc. (U.S.) Company Details
Table 84. BIOVIEW Inc. (U.S.) Business Overview
Table 85. BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 86. BIOVIEW Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 87. BIOVIEW Inc. (U.S.) Recent Development
Table 88. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Company Details
Table 89. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Business Overview
Table 90. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Product
Table 91. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Recent Development
Table 93. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Company Details
Table 94. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Business Overview
Table 95. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 96. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Recent Development
Table 98. Digene Corporation (U.S.) Company Details
Table 99. Digene Corporation (U.S.) Business Overview
Table 100. Digene Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Digene Corporation (U.S.) Recent Development
Table 102. Gen-Probe Incorporated (U.S.) Company Details
Table 103. Gen-Probe Incorporated (U.S.) Business Overview
Table 104. Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Product
Table 105. Gen-Probe Incorporated (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Gen-Probe Incorporated (U.S.) Recent Development
Table 107. IVDiagnostics, Inc. (U.S.) Company Details
Table 108. IVDiagnostics, Inc. (U.S.) Business Overview
Table 109. IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 110. IVDiagnostics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 111. IVDiagnostics, Inc. (U.S.) Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Noninvasive Cancer Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Clinical Chemistry Features
Figure 3. Immunochemistry/Immunoassay Features
Figure 4. Molecular Diagnostics Features
Figure 5. Others Features
Figure 6. Global Noninvasive Cancer Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Solid Tumors Case Studies
Figure 8. Blood Cancer Case Studies
Figure 9. Lung Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Noninvasive Cancer Diagnostics Report Years Considered
Figure 13. Global Noninvasive Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Noninvasive Cancer Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Noninvasive Cancer Diagnostics Market Share by Regions: 2020 VS 2027
Figure 16. Global Noninvasive Cancer Diagnostics Market Share by Regions (2022-2027)
Figure 17. Global Noninvasive Cancer Diagnostics Market Share by Players in 2020
Figure 18. Global Top Noninvasive Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Noninvasive Cancer Diagnostics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Noninvasive Cancer Diagnostics Revenue in 2020
Figure 20. Global Noninvasive Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Figure 21. Global Noninvasive Cancer Diagnostics Revenue Market Share by Type (2022-2027)
Figure 22. North America Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Noninvasive Cancer Diagnostics Market Share by Type (2016-2027)
Figure 24. North America Noninvasive Cancer Diagnostics Market Share by Application (2016-2027)
Figure 25. North America Noninvasive Cancer Diagnostics Market Share by Country (2016-2027)
Figure 26. United States Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Noninvasive Cancer Diagnostics Market Share by Type (2016-2027)
Figure 30. Europe Noninvasive Cancer Diagnostics Market Share by Application (2016-2027)
Figure 31. Europe Noninvasive Cancer Diagnostics Market Share by Country (2016-2027)
Figure 32. Germany Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Noninvasive Cancer Diagnostics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Noninvasive Cancer Diagnostics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Noninvasive Cancer Diagnostics Market Share by Region (2016-2027)
Figure 42. China Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Noninvasive Cancer Diagnostics Market Share by Type (2016-2027)
Figure 50. Latin America Noninvasive Cancer Diagnostics Market Share by Application (2016-2027)
Figure 51. Latin America Noninvasive Cancer Diagnostics Market Share by Country (2016-2027)
Figure 52. Mexico Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Noninvasive Cancer Diagnostics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Noninvasive Cancer Diagnostics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Noninvasive Cancer Diagnostics Market Share by Country (2016-2027)
Figure 58. Turkey Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Noninvasive Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Precision Therapeutics, Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 62. A&G Pharmaceutical, Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 63. Affymetrix Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 64. AVIVA Biosciences Corporation (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 65. BIOVIEW Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 66. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 67. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 68. Digene Corporation (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 69. Gen-Probe Incorporated (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 70. IVDiagnostics, Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の非侵襲的がん診断市場 2021：企業別、地域別、種類・用途別 The Noninvasive Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- 世界の非侵襲的癌診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-invasive Cancer Diagnosis Market The global Non-invasive Cancer Diagnosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界の結腸直腸がん分子診断市場規模・現状・予測（2021年-2027年） Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor to personalized medicine…
- 世界のがん診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Diagnostics Market The global Cancer Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…
- 世界の非侵襲的癌診断市場規模・現状・予測（2021年-2027年） Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of ri…